Get Healthy!

Results for search "Vaccines".

Health News Results - 1341

Biden Administration Says Insurance Issues With COVID Shots Mostly Fixed

FRIDAY, Sept. 29, 2023 (HealthDay News) – Despite reports of trouble last week where some people may have been denied insurance coverage while seeking COVID shots at pharmacies, the Biden administration said Thursday those issues have been ironed out.

That issue is "largely, if not completely," resolved after U.S. Health and Human Services Secretary Secretary

  • Cara Murez HealthDay Reporter
  • |
  • September 29, 2023
  • |
  • Full Page
  • Getting COVID Shot During Pregnancy Helps Protect Newborns, CDC Study Finds

    FRIDAY, Sept. 29, 2023 (HealthDay News) – When pregnant women get a COVID vaccine, it helps protect their newborns from the virus, a new government study shows.

    "These findings indicate that maternal vaccination during pregnancy could help prevent COVID-19–related hospitalization in infants too young to be vaccinated," researchers from the U.S. Centers for Disease Co...

    Just 23% of U.S. Adults 'Definitely' Plan to Get New COVID Shot

    Just 23% of American adults say they 'definitely' will get the new COVID-19 vaccine, while another 23% say they will 'probably' get it, according to a new poll, which also finds interest in the shot falls along partisan lines.

    More people plan to get seasonal flu shots and the new vaccine to help prevent severe symptoms for respiratory syncytial virus or RSV.

    The poll -- by...

    President Biden Gets COVID, Flu Shots

    MONDAY, Sept. 25, 2023 (HealthDay News) – President Joe Biden has been freshly vaccinated for three major respiratory viruses that could spread widely this fall and winter.

    Biden got both the updated COVID booster and his annual flu shot on Friday, White House physician

  • Cara Murez HealthDay Reporter
  • |
  • September 25, 2023
  • |
  • Full Page
  • RSV Vaccine Given in Pregnancy to Help Shield Newborns Receives Full U.S. Approval

    Women may soon have a vaccine they can take during a pregnancy to help protect their newborn from respiratory syncytial virus (RSV).

    Following approval one month ago by the U.S. Food and Drug Administration, the Centers for Disease Control and Prevention on Friday also approved the shot, called Abrysvo. That marks the last hurdle needed for the vaccine to become widely available.


    Many Americans Frustrated in Search for Low-Cost COVID Boosters

    Americans seeking out the new COVID boosters are finding themselves held back by insurance entanglements and supply delays.

    Some insurers have balked at covering the vaccines, with people arriving at shot appointments only to be told that they’ll have to pay $100 or more out of pocket for the jab.

    And in other places, booster appointments simply aren’t available due to supply s...

    Today's COVID Is Increasingly Looking Like a Cold or Flu

    Symptoms of mild COVID-19 infection have shifted this season, and now are more akin to those of allergies and the common cold, doctors say.

    Many people with COVID-19 now are presenting with upper respiratory symptoms like runny nose, watery eyes and a sore throat, said Dr. ...

    It's Time to Start Preparing Against Flu, RSV & COVID-19

    FRIDAY, Sept. 15, 2023 (HealthDay News) – Kids are back in school and it’s time to think about viruses, for both yourself and them.

    It could be an early flu season in the United States, if what happened in the Southern Hemisphere offers any insight, according to Cedars-Sinai in Los Angeles.

    The flu vaccine is now available in some locations. A new COVID-19 boost...

    A COVID Vaccine-by-Mouth Could Be on the Way

    An oral vaccine for COVID-19 appears to produce the sort of immune response that could quickly stamp out a developing infection, according to results from a small-scale primate study.

    Some monkeys given an experimental COVID vaccine tablet under their tongue developed the type of antibodies that might block the coronavirus as it attempts to infect the body through the mucous membranes of ...

    CDC Panel Gives Support to New COVID Booster Shots

    Following on an approval granted Monday by the U.S. Food and Drug Administration, an expert panel from the U.S. Centers for Disease Control and Prevention on Tuesday also signed off on new COVID boosters for Americans.

    Final approval is expected from CDC Director Dr. Mandy Cohen, which would set the stage for the updated vaccines to soon become available.

    The COVID-19 shots from Pf...

    FDA Approves New COVID Booster Shots

    The U.S. Food and Drug Administration on Monday gave the green light to new COVID boosters for Americans, setting the stage for the updated vaccines to become available within days.

    The COVID-19 shots from Pfizer and Moderna will join the flu shot and newly approved RSV shots as part of a three-pronged public health strategy to tame the spread of all three viruses this coming winter. The ...

    In Good News for U.S., Flu Vaccine Working Well in South America

    MONDAY, Sept. 11, 2023 (HealthDay News) – In a finding that should ease the minds of Americans ahead of another flu season, this year's vaccines have already cut the risk of hospitalization in half during the South American winter, health officials report.

    Even better, the flu virus strains that have been detected in the United States have so far shown a similar pattern to those in Sout...

    Anti-Vax Trend May Harm Pet Dogs, With Half of Owners Against Immunization

    Some people mistrust the safety and effectiveness of human vaccines for COVID-19 and other diseases, a fact that became abundantly clear during the pandemic.

    Now, a new survey of 2,200 dog owners shows this mistrust may often extend to canine vaccinations.

    The finding suggests there is spillover between the issues, with those who have negative feelings about human vaccines more lik...

    FDA Approval of New COVID Boosters Could Come by Friday

    New COVID-19 booster shots could soon pass the needed hurdles for vaccinations to begin next week.

    Sources familiar with U.S. Food and Drug Administration plans say boosters could be approved as soon as Friday, NBC News reported.

    The U.S. Centers for Disease Control and Prevention Advisory Committee on Immunization Practices is scheduled to meet on Tuesday. CDC director

    Making Sure You Don't Get RSV This Winter: An Expert Offers Tips

    Respiratory syncytial virus (RSV) is a common viral infection that affects people of all ages, with infants and older adults being particularly vulnerable to severe complications.

    Preventing the spread of RSV requires a multi-pronged approach that includes vaccination, good hygiene practices and public health initiatives.

    You may have seen recent reports about newly approved vacci...

    • Todd A. Mahr, MD, Executive Medical Director, American College Of Allergy, Asthma And Immunology HealthDay Reporter
    • |
    • September 7, 2023
    • |
    • Full Page
    Study Confirms Effectiveness of Mpox Vaccine

    While it doesn't prevent infection altogether, new research shows the mpox vaccine does reduces the severity of disease in those who fall ill from the virus.

    An international team of scientists found that those people who had either mpox vaccination or a previous infection in 2022 had less severe disease.

    The researchers studied 38 mpox infections in 37 gay and bisexual men; among ...

    Moderna Says Updated COVID Shot Shields Against Highly Mutated New Variant

    Some good news for folks who are worried about the new, troublesome COVID variant known as BA.2.86: Moderna Inc. said Wednesday that its updated vaccine held its own against this highly mutated version of the virus.

    While approval for the newest version of the vaccine is still pending from the U.S. Food and Drug Administration, the company offered good reason for why the agency should gi...

    Rising COVID Hospitalizations, New Variants Have Americans on Edge

    A new COVID-19 surge is underway, with seasonal changes and new variants fueling an increase in hospitalizations and deaths.

    A new Omicron variant, named Eris, has become dominant in the United States amid signs that an even more highly evolved COVID variant called BA.2.86 is starting to spread across America.

    However, experts say the public should react to this latest surge not wit...

    Updated COVID Vaccines Will Roll Out Mid-September, Officials Say

    New COVID-19 booster shots, reworked to target variants circulating now, could be available by mid-September.

    The U.S. Food and Drug Administration is expected to approve them in a few weeks, CNN reported, citing unnamed senior administration officials.

    The U.S. Centers for Disease Control and Prevention will soon follow with a safety review and its recommendations. Its Adv...

    U.S. Kids’ HPV Vaccination Rate Has Stalled

    For the first time in a decade, the rate at which American adolescents received the human papillomavirus (HPV) vaccine has not increased, new data show.

    Current guidelines from the U.S. Centers for Disease Control and Prevention recommend that both girls and boys receive t...

    U.S. Wastewater Tests Spot Highly Mutated Variant of COVID-19

    Public health officials have detected the new BA.2.86 variant of COVID-19 in U.S. wastewater, giving rise to concerns about the highly mutated variant in the United States.

    The U.S. Centers for Disease Control and Prevention announced the detection on Wednesday. ...

    COVID Vaccine Boosters Crucial for Some Cancer Patients: Study

    Cancer patients with immune systems weakened by treatment are among the groups most concerned about the continued spread of COVID-19 and the chance of the infection becoming severe.

    New research suggests more guidance on how often these patients need protective booster shots.

    It’s not one-size-fits-all, but depends on the specific treatment, said scientists...

    FDA Approves RSV Vaccine for Pregnant Women to Help Shield Newborns

    Women may soon have a vaccine they can take during a pregnancy to help protect their newborn from respiratory syncytial virus (RSV), following U.S. Food and Drug Administration approval of the shot, called Abrysvo, on Monday

    The vaccine is designed to be given to pregnant women between 32 and 36 weeks of pregnancy as a way to protect infants from birth through 6 months from the sometimes ...

    Poll Shows Who Americans Trust (and Don't Trust) for Health News

    Misinformation about health and medicine is rampant in the United States, with far too many Americans being presented false claims and left wondering what to believe, a new survey reports.

    At least 4 in 10 people say they’ve heard 10 specific false claims about COVID-19, reproductive health and gun violence,

  • Dennis Thompson HealthDay Reporter
  • |
  • August 22, 2023
  • |
  • Full Page
  • Vaccines Against Shingles, Pneumonia May Also Lower Your Alzheimer's Risk

    Certain adult vaccines, including shingles and pneumonia shots, may also help seniors fight off Alzheimer's disease, new research reveals.

    Prior vaccination with the shingles vaccine, pneumococcus vaccine or the tetanus and diphtheria shot, with or without an added pertussis vaccine, are associated with a 25% to 30% reduced risk of Alzheimer’s disease, according to researchers from...

    Does Prior Omicron Infection Shield Against Future Infection? Maybe Not

    People may assume that a COVID-19 infection protects them the next time they encounter the virus, but that’s not necessarily true.

    A new study of 750 vaccinated seniors living in retirement homes and long-term care facilities found that those infected during the first omicron wave were actually more vulnerable to reinfection with a later wave.

    "This research highlights the need f...

    'Do Your Own Research': Was It Dangerous Advice During the Pandemic?

    The idea of “doing your own research” didn’t begin with the pandemic, but new research suggests that those who follow that ideology have been more likely to believe COVID misinformation.

    “We had heard the phrase a lot before,” prior to the pandemic, said researcher Sedona Chinn, a professor of life science...

    Pediatricians' Group Urges That All Infants Get New RSV Shot

    All infants should receive the new long-acting preventive monoclonal antibody for respiratory syncytial virus (RSV), the nation's leading pediatrics group said.

    The American Academy of Pediatrics (AAP) urged that access to the new medication, called nirsevimab, be equitable.

    RSV is common, contagious and sometimes deadly, the AAP said.

    The antibody boosts the immune system.

    Most Infants Hospitalized With RSV Were Otherwise Healthy, Study Finds

    As experts begin preparing for another season of viruses, they now know that even healthy infants with no underlying health issues are at risk for severe respiratory syncytial virus (RSV).

    New research finds that most infants who were admitted last fall to an intensive care unit for RSV were generally healthy before their infection. So, preventative measures -- including a newly approved ...

    New COVID Variant EG.5 Now Dominant in U.S., CDC Says

    A variant nicknamed Eris now accounts for the largest proportion of new COVID infections across America.

    About 17.3% of U.S. COVID cases are believed to have been caused by the variant, formally known as EG.5, in early August, according to the U.S. Centers for Disease Control and Prevention. That number is 7.5% higher than it was in early July.

    Other dominant variants include XBB.1....

    How the COVID Vaccine Is Keeping Folks Out of the Hospital

    Most people know that even though vaccination doesn't eliminate their risk of getting COVID-19, it does lower their odds for severe illness -- including their risk for hospitalization and death.

    Now scientists believe they know why.

    Among people with a symptomatic COVID infection, those who were fully vaccinated had fewer markers of inflammation compared to those who were unvaccina...

    One Personality Type Is More Prone to Be an Anti-Vaxxer

    When studying which personality types were more likely to resist getting vaccines, researchers got a surprise.

    It was the extroverts who were more vaccine resistant. Compared to other personality styles, extroverts were 18% more likely to refuse the COVID-19 vaccine, the new study finds.

    “We expected that people who were especially high in extroversion would be more likely to ge...

    Moderna or Pfizer? One COVID Shot May Be Safer for Older Adults

    While both the Moderna and Pfizer COVID-19 vaccines are considered safe and highly effective, new research finds the Moderna shot has been the safest and most effective for seniors.

    “The results of this study can help public health experts weigh which mRNA vaccine might be preferred for older adults and older subgroups, such as those with increased frailty,” said lead study author

    1 in 6 Kids Haven't Gotten All of Their Vaccines. Why?

    Most early childhood vaccines require three or four doses for best protection, but more than 1 in 6 toddlers aren't getting them all, leaving them vulnerable to potentially deadly infections, a new study finds.

    There are many reasons that kids aren't completing their vaccine series, according to researchers. Some families may have moved across state lines and others may lack health insura...

    FDA Approves New Drug to Protect Against RSV in Infants

    MONDAY, July 17, 2023 (HealthDay Now) -- Parents now have a new long-acting drug to protect their children against respiratory syncytial virus (RSV), a common germ that hospitalizes as many as 3% of children under the age of 1 in the United States each year.

    The U.S. Food and Drug Administration on Monday

  • Dennis Thompson HealthDay Reporter
  • |
  • July 17, 2023
  • |
  • Full Page
  • CDC Gives Full Approval to RSV Shots for People Over 60; Vaccines Available This Fall

    Americans ages 60 and up can get their vaccine for respiratory syncytial virus (RSV) this fall, the U.S. Centers for Disease Control and Prevention announced Thursday.

    On Thursday, Dr. Rochelle Walensky, the outgoing CDC director, gave her signature to a recommendation made last week by an advisory panel of outside experts for a single dose of the vaccines made by Pfizer and GSK. The FDA ...

    CDC Panel Backs RSV Shots for Seniors

    An advisory panel of the U.S.Centers for Disease Control and Prevention voted on Wednesday to recommend the first RSV vaccines for seniors.

    The U.S. Food and Drug Administration has already approved the vaccines, one made by GSK called Arexvy and a v...

    FDA Advisers Say Next Round of COVID Booster Shots Should  Target an XBB Variant

    An advisory panel to the U.S. Food and Drug Administration voted unanimously on Thursday to recommend that COVID booster shots be updated for the fall to protect solely against one of the three XBB variants that have taken hold in the United States.

    Those three XBB variants, which are all sublineages of the Omicron variant, are XBB.1.5, XBB.1.16 and XBB.2.3, CNN reported. What wi...

    FDA Advisers Meet to Decide Next COVID Booster Shot

    COVID-19 boosters may be offered this fall, but first scientists need to determine what strains to target and who should receive the shots.

    Advisers to the U.S. Food and Drug Administration are slated to meet Thursday to discuss plans for fall, a decision with a deadline because drugmakers will need to have the time to manufacture the shots, NBC News reported.

    The process i...

    There's No Hepatitis C Vaccine, But You Can Still Prevent Infection

    Hepatitis C can ruin your liver, and there's no vaccine to prevent it, but you can take steps to lower your chances of infection.

    According to the U.S. Centers for Disease Control and Prevention,...

    FDA Panel Backs RSV Vaccine for Infants, Some Toddlers

    A U.S. Food and Drug Administration advisory panel on Thursday recommended that the agency approve an RSV vaccine for infants and some toddlers.

    The monoclonal antibody shot would protect against respiratory syncytial virus (RSV) in infants born during or entering their first RSV season, the New York Times reported. It could also be used for toddlers up to 24 months old who are p...

    1 in 6 Unvaccinated People Struggle With Symptoms 2 Years After Getting COVID

    People unvaccinated for COVID-19 have significant odds of lingering illness if they get the virus, with one in six still suffering symptoms two years later, new research shows.

    A study from Switzerland found that 17% of that group did not return to their previously normal health, and 18% reported COVID symptoms such as shortness of breath 24 months after their infection was gone.


    FDA Approves Pfizer's RSV Shot for Older Adults

    Older adults may have a second vaccine option for RSV following the U.S. Food and Drug Administration's approval of a Pfizer vaccine on Wednesday.

    The other shot for adults 60 and up is made by GSK. It was approved May 3.

    Both should be available by fall, before the seasonal spread of respiratory syncytial virus (RSV), The New York Times reported.

    The Pfizer ...

    HPV: What It Is, Symptoms in Men vs. Women & Treatment

    Talking about sexually transmitted infections (STIs) can be uncomfortable. But whether you're talking to your partner, child or doctor, these are important conversations to have.

    The U.S. Centers for Disease Control and Prevention estimates 20% of Americans had an STI...

    More Mpox Cases Reported as Health Officials Fear a Summer Resurgence

    U.S. health officials are bracing for the possibility that mpox could surge again this summer as cases mount in several states.

    On Thursday, the U.S. Centers for Disease Control and Prevention reported 21 more cases of mpox, with Illinois, New York and Maryland reporting the most new infections. Illi...

    Got Smallpox Vaccine as a Child? You're Probably Immune to Mpox

    Smallpox vaccines, which were routinely given into the 1970s, seem to provide protection from mpox, a new study says.

    The mpox virus, responsible for a worldwide outbreak last year, could surge again this summer, public health experts have warned. It was previously called monkeypox.

    Researchers at the Karolinska Institute in Sweden wondered whether the smallpox vaccine would offer ...

    Parents' Mistrust of HPV Vaccine May Be Growing

    It was a no-brainer for New York City mom Jen L. when a pediatrician suggested that she vaccinate her two sons against human papillomavirus (HPV).

    “Before my kids were eligible for the vaccine, I had read up on it to learn about the vaccine and its positives in general, and also to learn if there were any significant side effects," she said. “I have a good friend who had issues f...

    FDA Panel Backs First RSV Vaccine Given in Pregnancy to Protect Infants

    The first vaccine designed to protect infants against respiratory syncytial virus (RSV) by vaccinating their mothers during pregnancy has been backed by a panel of advisers to the U.S. Food and Drug Administration.

    On Thursday the independent committee of experts voted unanimously that the Pfizer-made vaccine was effective, and 10-4 that there was adequate data on safety to move the vacci...

    FDA Panel to Vote on First RSV Vaccine Given in Pregnancy to Protect Infants

    The first RSV vaccine designed to protect infants is under consideration by a panel of advisers to the U.S. Food and Drug Administration.

    An independent committee of experts will vote Thursday on whether to recommend the shot for pregnant mothers at 24 to 36 weeks gestation.

    “Before the pandemic, RSV was the No. 1 cause of infant hospitalization in the United States, so this ...

    Severe Obesity Could Mean Faster Decline of Immunity From COVID Shot

    Severely obese people may need more frequent COVID-19 booster shots to keep their immunity going, new research suggests.

    Protection from the shots declines more rapidly in those who are severely obese compared to those at a normal weight, according to scientists at the Universities of Cambridge and Edinburgh in the United Kingdom.

    "Because of the high prevalence of obesity across ...

    Show All Health News Results